CRISPR gene editing shows promise for treating individuals with a form of inherited blindness

FHS
May 6, 2024
5:03 pm

Results from a groundbreaking clinical trial of CRISPR gene editing in 14 individuals with a form of inherited blindness show that the treatment is safe and led to measurable improvements in 11 of the participants treated.

Smartwatches prove effective in detecting heart arrhythmias in children

Study explores the use of smartwatches for diagnosing arrhythmias in children, revealing their potential to identify cardiac irregularities that traditional methods may miss.

December 18, 2023

FDA Advisory Panel Generally Pleased With Pulse Oximetry Clinical Trial Proposal

An FDA advisory committee gave generally high marks to the agency’s latest effort to improve the accuracy of pulse oximeters when used in darker-skinned patients,

February 4, 2024

Are inflammatory bowel disease patients more at risk of colorectal cancer?

Researchers analyzed data from a large cohort of inflammatory bowel disease patients and looked at the risk and frequency of colorectal cancer.

August 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.